Pilar
García Alfonso
Publicacións nas que colabora con Pilar García Alfonso (5)
2021
-
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231
2019
-
Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial (Cancer Chemotherapy and Pharmacology, (2019), 83, 6, (1175-1181), 10.1007/s00280-019-03820-7)
Cancer Chemotherapy and Pharmacology
-
First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: A pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
BMC Cancer, Vol. 19, Núm. 1
-
Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial
Cancer Chemotherapy and Pharmacology, Vol. 83, Núm. 6, pp. 1175-1181